MedTrace Logo

Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis

NCT03099408 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2021-02-01

No results posted yet for this study

Summary

We are trying to determine if Oral Metronidazole with Lactobacillus Vaginal Suppositories is better than Oral Metronidazole in Preventing the Recurrence of Bacterial Vaginosis

Conditions

  • Bacterial Vaginosis
  • Recurrence

Interventions

DRUG

Metronidazole Oral

Oral metronidazole 400 mg BID for 7 days at first month.

DRUG

"Metronidazole" and "Lactobacillus"

Oral metronidazole metronidazole 400 mg BID for 7 days at first month and Lactobacillus vaginal suppositories for 10 days at first month,second month and third month.

Sponsors & Collaborators

  • Peking University Shenzhen Hospital

    lead OTHER

Principal Investigators

  • Shangrong Fan, M.D. · Peking University Shenzhen Hospital

  • Salvatore Giovanni Vitale, M.D. · Department of Human Pathology in Adulthood and Childhood, University of Messina (Italy)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03099408 on ClinicalTrials.gov